首页|舍曲林联合右佐匹克隆治疗脑卒中后抑郁的临床效果及对睡眠质量的影响

舍曲林联合右佐匹克隆治疗脑卒中后抑郁的临床效果及对睡眠质量的影响

扫码查看
目的 分析脑卒中后抑郁患者以舍曲林联合右佐匹克隆方式展开临床治疗的效果,并探究对患者睡眠质量的影响.方法 选取2020年10月—2022年12月赤峰市医院神经内科收治的72例脑卒中后抑郁患者作为研究对象,以单盲分组方法实施组别划分,分为参照组(n=36)与研究组(n=36),参照组以舍曲林为患者实施药物治疗,研究组以舍曲林联合右佐匹克隆方式为患者实施药物治疗,对两组患者临床治疗效果进行比较.结果 研究组的总有效率(94.44%)高于参照组,差异有统计学意义(χ2=6.400,P<0.05);治疗后,研究组的血清中枢神经特异蛋白显著低于参照组,且脑源性神经营养因子明显高于参照组,差异有统计学意义(P均<0.05);治疗后,研究组的神经功能缺损评估量表评分、匹兹堡睡眠质量指数量表评分、汉密顿抑郁量表评分、汉密尔顿焦虑量表评分均低于参照组,差异有统计学意义(P均<0.05);研究组的超敏C反应蛋白低于参照组,且血管内皮生长因子高于参照组,差异有统计学意义(P均<0.05).结论 脑卒中后抑郁患者以舍曲林联合右佐匹克隆方式实施药物治疗,可改善患者神经功能与睡眠质量,有助于患者临床治疗效果的提升,对缓解患者抑郁症状具有积极意义.
Clinical Effect of Sertraline Combined with Eszopiclone in the Treatment of Post-stroke Depression and the Impact on Sleep Quality
Objective To analyze the clinical effect of sertraline combined with dexzopiclone in patients with post-stroke depression,and explore the effect on sleep quality of patients.Methods A total of 72 patients with post-stroke depression admitted to the Department of Neurology of Chifeng Hospital from October 2020 to December 2022 were selected as the study objects.The group was divided into the reference group(n=36)and the study group(n=36)by single-blind grouping method.The reference group was treated with sertralin.The study group used sertraline com-bined with dexzopiclone as drug therapy for the patients,and compared the clinical therapeutic effect of the two groups of patients.Results The total effective rate of the study group(94.44%)was higher than that of the reference group,and the difference was statistically significant(χ2=6.400,P<0.05).After treatment,the serum central nerve spe-cific protein of the study group was significantly lower than that of the reference group,and the brain-derived neuro-trophic factor was significantly higher than that of the reference group,and the differences were statistically significant(both P<0.05).After treatment,the National Institute of Health Stroke Scale scores,Pittsburgh Sleep Quality Index scores,Hamilton Depression Scale scores,Hamilton Anxiety Scale scores of the study group were lower than those of the reference group,and the differences were statistically significant(all P<0.05).The hypersensitive C-reactive pro-tein in the study group was lower than that in the reference group,and the vascular endothelial growth factor was higher than that in the reference group,and the differences were statistically significant(both P<0.05).Conclusion The drug treatment of post-stroke depression patients with sertraline combined with eszopiclone can improve the pa-tients'neurological function and sleep quality,contribute to the enhancement of the patients'clinical therapeutic ef-fect,and have a positive significance in alleviating the patients'depressive symptoms.

StrokeDepressionSertralineEszopicloneSleep qualityNeurological function

段思玉、刘晓凯、赵岩

展开 >

赤峰市医院神经内科,内蒙古赤峰 024000

脑卒中 抑郁 舍曲林 右佐匹克隆 睡眠质量 神经功能

2024

系统医学

系统医学

ISSN:
年,卷(期):2024.9(3)
  • 15